All right. Thanks, David, and good morning. First, let me take a moment to address the issues associated with the postponement of this earnings call yesterday. As you know, all relevant information related to the Company's filings, a filing period must be considered up to the filing of the 10-Q or 10-K. That said, we received certain new information late on Monday evening that required us to review for potential financial impacts. We're able to complete the review on Tuesday and are happy to be able to report our earnings today. We apologize for any inconvenience or impacts associated with this delay, but deemed the delay necessary to ensure the accuracy of our financial statements. While 2022 was a challenging year due to the lingering effects of COVID-19 pandemic, we believe we're back on the growth trajectory that we were working so hard for. We are finally starting to realize improvements in our performance and the momentum we had prior to the pandemic as evidenced by our results this quarter. I'm pleased to report we achieved a 26.3% increase in revenue and an 83.9% increase in gross profit for the first quarter of 2023 compared to the same period last year. Importantly, we also achieved sequential growth of 20% compared to the fourth quarter of 2022 even though the first quarter tends to be traditionally a seasonally weak period for us. We saw steady improvement throughout the quarter including a strong March, which has continued into the second quarter. It's also worth noting that revenue increased both within our Treatment and our Services segment. The growth in revenue reflects the initiation of several new projects in the first quarter of 2023 that support the backlog in both segments and provide growth opportunities into 2024. As we've recently announced, we were awarded eight new contracts over the past few months totaling approximately $15 million of revenue that's expected to be recognized in 2023 with additional option phases that have a potential value of over $14 million moving forward. These projects included the deployment of our sole solar technology for providing a remediation solution to the abandoned uranium mine program through the EPA, as well as the remediation of dredging settlements for the Department of Defense in San Diego. Other new contracts have been initiated in support of the Los Alamos National Lab and providing an innovative technology for on-site decontamination support for the decommissioning of a nuclear power plant. In addition to this new backlog, we've realized significant increases in bidding activities with recent opportunities requiring our core competencies in support of the DOE remediation programs as well as the Army Corps of Engineers’ cleanup initiatives, U.S. Navy decommissioning projects and several international projects with sustainable revenue potential. Within our Treatment segment, we benefited from a steady improvement in waste receipts. This was a result of increased waste shipments from DOE and expanding our current waste treatment offering to the commercial utility sector. Along with the oil and gas markets and the growth in our industrial waste programs as well. We recently received a new IDIQ contract with a regional power utility to provide waste treatment services over the next five years. Once this contract is signed, we will open the -- this will open the door for new opportunities within utility markets that we've not seen in the past. We expect to see continued improvement in waste receipts and an increase in project work through existing contracts, recently won contracts and bids submitted in both segments that are waiting for awards now. We expect this positive trend to continue over the next several quarters as lingering effects of the COVID-19 pandemic continue to subside. At the same time, we're rapidly advancing several initiatives that we believe have the potential to significantly enhance our revenues and our long-term backlog. Towards this end, we have realized two important steps towards the Department of Energy, but with Department of Energy, the pursuit of the Hanford tank our remediation mission, these include the amendment of the record decision for the direct feed, low activity waste facility, DFLAW, and the approval of the waste incidental to reprocessing or WIR report, which represent opportunities to provide large scale waste treatment services at Hanford. These announcements underscore the importance of our role in DOE strategy for the treatment of Hanford tank waste through the vitrification program that is currently in the final construction phases and start up. This waste estimated by DOE to be over 8000 cubic meters annually will be more than double our current annual production rate at our plants combined. And given the fixed cost nature of our business, we have significant positive impact from this on profitability over the next 10 years. The outlook of the Test Bed Initiative what we refer to as TBI, which also is known as the low level waste off-site disposal project, in support of the DOE Hanford tank disposition program continues to be recognized by DOE as a potential supplement to the vitrification mission to provide a solution for the 59 million gallons of tank waste stored at the site. TBI program, which is based on the grounding technology, continues to progress and we expect to receive the next 2000 gallons of tank waste within the next few quarters. Perma-Fix maintains these capabilities today at our Perma-Fix Northwest facility, which is permitted and outfitted to safely and compliantly grout up to 30,000 gallons per month with the ability to expand to over million gallons a year while dramatically reducing cost compared to vitrification. We're also pursuing several additional international waste opportunities that we believe will provide sustainable revenue in the latter half of this year in both the Services and Treatment segments. We remain optimistic about the announcement which could be any day now of a key procurement in Italy that would support our expansion program throughout Europe. This announcement in addition to the near-term opportunities we have in Slovenia, Croatia, Mexico, Canada and the UK and Germany will provide an increased market potential that will leverage our technologies and our core competencies. In addition, we're pursuing several large waste processing opportunities at large DOE sites that could include waste inventories that have been backed up due to COVID as well as the lack of available technologies to provide high efficiency processing. These waste are expected to provide sustained receipts through the next three or four quarters providing an opportunity from $10 million to $20 million potential annual revenue. Turning back to our financials for a moment, EBITDA in Q1 of 2023 improved to an income of $171,000 compared to a loss of $1.4 million in Q1 of 2022. Aside from our expectations for revenue growth having a positive impact on our EBITDA going forward, we continue to focus on a reduction in our SG&A expenses and billable indirect operating costs. As a result, we anticipate a meaningful improvement in profitability and cash flow going forward. So to wrap up, it's clear to us there is a solid federal budget and a significant backlog of demand that we expect to capitalize on going forward. As a result, we remain confident the balance of 2023 will see a significant improvement over 2022. And as I mentioned earlier, we're seeing continued momentum heading into the second quarter. We continue to invest in our capabilities and our facilities and have a highly scalable infrastructure and believe that we're in a great position to take advantage of this pent up demand. As we continue to increase revenues, we expect to benefit from the predictable cash flows of our Services segment and high incremental margins within our Treatment segment. As a result, we believe we're well positioned to exceed the performance of profitability we had attained prior to the pandemic through increased bidding activities, waste treatment capability expansion and improved federal budgets. On that note, I'll now turn the call over to Ben, who will discuss the financial results in more detail, Ben.